Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort
LAW, W. Phillip, DUNCOMBE, Chris J, MAHANONTHARIT, Apicha, BOYD, Mark A, RUXRUNGTHAM, Kiat, LANGE, Joep M. A, PHANUPHAK, Praphan, COOPER, David A, DORE, Gregory J
Published in AIDS (London) (21.05.2004)
Published in AIDS (London) (21.05.2004)
Get full text
Journal Article
Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001
LAW, W. Phillip, DORE, Gregory J, DUNCOMBE, Chris J, MAHANONTHARIT, Apicha, BOYD, Mark A, RUXRUNGTHAM, Kiat, LANGE, Joep M. A, PHANUPHAK, Praphan, COOPER, David A
Published in AIDS (London) (17.10.2003)
Published in AIDS (London) (17.10.2003)
Get full text
Journal Article
Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96‐week outcomes of HIV‐NAT 009
Boyd, MA, Siangphoe, U, Ruxrungtham, K, Duncombe, CJ, Stek, M, Lange, JMA, Cooper, DA, Phanuphak, P
Published in HIV medicine (01.11.2005)
Published in HIV medicine (01.11.2005)
Get full text
Journal Article